BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Astellas Pharma US 

1 Astellas Way

Northbrook  Illinois  60062  U.S.A.
Phone: 800-695-4321 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical

Segment
Pharmaceuticals

Collaborations

Gilead 

Gilead (Seattle, WA) 





 Company News
Astellas Pharma US Release: Mirabegron As Add-On Treatment To Solifenacin Therapy Demonstrated Superior Results To Solifenacin Monotherapy In BESIDE Trial 5/18/2015 6:35:05 AM
Astellas Pharma US Release: CRESEMBA (Isavuconazonium Sulfate) Data To Be Presented At The European Congress Of Clinical Microbiology And Infectious Diseases 4/24/2015 12:30:24 PM
Astellas Pharma US And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics 4/22/2015 11:05:38 AM
Astellas Pharma US Teams Up With The Chris Klug Foundation On The Bounce Back Award To Recognize Extraordinary Transplant Recipients 4/2/2015 7:33:41 AM
Astellas Pharma US Release: New Enzalutamide Data To Be Presented In Late Breaking News Plenary Session At European Association Of Urology Congress 3/17/2015 10:04:13 AM
Astellas Pharma US And BlackDoctor.org (BDO) Team Up To Offer Health Education At The 2015 CIAA Tournament Fan Fest 2/20/2015 1:37:13 PM
Astellas Pharma US Release: XTANDI™ (Enzalutamide) Now Approved In Europe For The Treatment Of Men With Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy-Naïve 12/2/2014 9:16:16 AM
Medivation, Inc. (MDVN) And Astellas Pharma US Announce Phase 3 Study Of Enzalutamide in Men With High-Risk, Hormone-Sensitive, Non-Metastatic Prostate Cancer That Has Recurred Following Definitive Local Therapy 10/31/2014 12:45:31 PM
Astellas Pharma US Teams Up With USA Rugby And Men's Health Network To Encourage Chicagoans To Answer The Challenge For Better Health 10/15/2014 8:13:43 AM
Brian McLellan Promoted To President Of Astellas Pharma US 10/2/2014 8:46:16 AM
123456789